MarketMoodz
HSBC's Bullish Call on Gilead Leads Five Major Upgrades
HSBC upgraded Gilead Sciences to Buy Monday, joining four other major-bank upgrades across telecom, banking, cybersecurity and energy retail. The cluster — including BofA on T‑Mobile and Jefferies on U.S. Bancorp — creates near‑term trading catalysts and clear risk/reward snapshots for investors ahead of catalysts like FDA timelines and earnings windows.
Key Takeaways
- HSBC moved Gilead Sciences (GILD) to Buy with a $155 price target, implying roughly 17% upside from a $132.42 close.
- BofA’s Michael Funk upgraded T‑Mobile US (TMUS) to Buy with a $220 target, implying about 22% upside from $180.76.
- Jefferies’ David Chiaverini upgraded U.S. Bancorp (USB) to Buy with a $75 target, implying roughly 20% upside from $62.60.
- Scotiabank’s Patrick Colville raised Tenable Holdings (TENB) to Sector Outperform with a $50 target, implying about 27% upside from $39.29.
- Goldman’s Bonnie Herzog moved Murphy USA (MUSA) to Neutral with a $550 target, implying roughly a 4% downside from a $573.00 close, signaling a defensive stance.
People Involved
- Morten Herholdt HSBC analyst (Gilead upgrade)
- Michael Funk BofA Securities analyst (T‑Mobile upgrade)
- David Chiaverini Jefferies analyst (U.S. Bancorp upgrade)
- Patrick Colville Scotiabank analyst (Tenable upgrade)
- Bonnie Herzog Goldman Sachs analyst (Murphy USA coverage change)
Entities Involved
- Gilead Sciences (GILD) Biotech company upgraded to Buy by HSBC
- T‑Mobile US (TMUS) Telecom upgraded to Buy by BofA Securities
- U.S. Bancorp (USB) Regional bank upgraded to Buy by Jefferies
- Tenable Holdings (TENB) Cybersecurity company raised to Sector Outperform by Scotiabank
- Murphy USA (MUSA) Energy retail chain moved to Neutral by Goldman Sachs
- HSBC Research firm issuing Gilead upgrade and $155 price target
- BofA Securities Research firm issuing T‑Mobile upgrade and $220 price target
- Jefferies Research firm issuing U.S. Bancorp upgrade and $75 price target
- Scotiabank Research firm issuing Tenable upgrade and $50 price target
- Goldman Sachs Research firm issuing Murphy USA coverage change and $550 price target
- Benzinga News outlet reporting the cluster of upgrades
MarketMoodz Analysis
Analyst upgrades compress uncertainty into digestible trade ideas — price target, catalyst and timeline — and this Monday’s cluster spans five large names across sectors. For active traders, the clearest opportunities are T‑Mobile, U.S. Bancorp, Tenable and Gilead, where targets imply 17%–27% upside; those names are likely to see higher volume as momentum traders chase the calls. Murphy USA is an outlier: Goldman’s Neutral and $550 target sits below the recent $573 close, which signals valuation caution rather than a bullish push and may cap near‑term upside despite the firm’s coverage change.
For longer‑term investors, these moves matter as signals of institutional sentiment but not as standalone investment mandates. Gilead’s upgrade is the most actionable on a fundamental level because biotech upside often tracks discrete events — trial readouts, partnerships and FDA decisions — that can validate a new thesis. Historically, clusters of upgrades across sectors can presage short‑term rotation into those areas, especially when multiple large houses participate; watch sector ETFs and block trade activity for confirmation.
What to watch next: verify each research note for methodology and timing, since the Benzinga report is the single aggregated source cited here. Monitor near‑term catalysts — Gilead pipeline dates and regulatory windows, Tenable’s earnings cadence, bank loan‑growth metrics for U.S. Bancorp, and T‑Mobile’s subscriber trends — and track volume and options flow for signs of conviction. If price action fails to follow the stated targets within weeks, treat the upgrades as transient headlines rather than durable thesis shifts.
Source: Original Article